tiprankstipranks
Trending News
More News >
Universe Pharmaceuticals (UPC)
NASDAQ:UPC
US Market

Universe Pharmaceuticals (UPC) Financial Statements

Compare
212 Followers

Universe Pharmaceuticals Financial Overview

Universe Pharmaceuticals's market cap is currently $2.34M. The company's EPS TTM is $-9.444; its P/E ratio is ―; Universe Pharmaceuticals is scheduled to report earnings on August 4, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 23.02M$ 32.31M$ 40.14M$ 47.98M$ 30.70M
Gross Profit$ 6.07M$ 10.32M$ 21.89M$ 25.33M$ 14.09M
Operating Income$ -8.02M$ -3.53M$ -7.02M$ 13.59M$ 10.25M
EBITDA$ -7.36M$ -3.18M$ -6.40M$ 14.20M$ 10.61M
Net Income$ -8.73M$ -6.16M$ -8.74M$ 11.32M$ 7.56M
Balance Sheet
Cash & Short-Term Investments$ 29.50M$ 18.50M$ 18.86M$ 21.80M$ 10.06M
Total Assets$ 67.95M$ 53.29M$ 59.54M$ 70.14M$ 28.80M
Total Debt$ 7.99M$ 5.48M$ 3.94M$ 4.33M$ 2.65M
Net Debt$ -21.50M$ 197.21K$ -1.78M$ -3.74M$ -7.41M
Total Liabilities$ 22.45M$ 13.75M$ 13.10M$ 11.21M$ 8.00M
Stockholders' Equity$ 45.50M$ 39.53M$ 46.44M$ 58.93M$ 20.80M
Cash Flow
Free Cash Flow$ -9.87M$ 1.08M$ -1.41M$ -15.59M$ 6.06M
Operating Cash Flow$ -9.51M$ 1.12M$ -1.31M$ -2.06M$ 6.12M
Investing Cash Flow$ -361.29K$ -44.17K$ -3.91M$ -27.06M$ -51.80K
Financing Cash Flow$ 33.95M$ -1.39M$ 3.32M$ 26.58M$ 470.14K
Currency in USD

Universe Pharmaceuticals Earnings and Revenue History

Universe Pharmaceuticals Debt to Assets

Universe Pharmaceuticals Cash Flow

Universe Pharmaceuticals Forecast EPS vs Actual EPS